Pharmacoepidemiology (eBook, PDF)
Redaktion: Strom, Brian L.; Hennessy, Sean; Kimmel, Stephen E.
251,99 €
251,99 €
inkl. MwSt.
Sofort per Download lieferbar
0 °P sammeln
251,99 €
Als Download kaufen
251,99 €
inkl. MwSt.
Sofort per Download lieferbar
0 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
251,99 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
0 °P sammeln
Pharmacoepidemiology (eBook, PDF)
Redaktion: Strom, Brian L.; Hennessy, Sean; Kimmel, Stephen E.
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This classic, field-defining textbook, now in its sixth edition, provides the most comprehensive guidance available for anyone needing up-to-date information in pharmacoepidemiology. This edition has been fully revised and updated throughout and continues to provide a rounded view on all perspectives from academia, industry and regulatory bodies, addressing data sources, applications and methodologies with great clarity.
- Geräte: PC
- mit Kopierschutz
- eBook Hilfe
- Größe: 11.1MB
Andere Kunden interessierten sich auch für
- Pharmacoepidemiology (eBook, ePUB)251,99 €
- Richard KayStatistical Thinking for Non-Statisticians in Drug Regulation (eBook, PDF)68,99 €
- Clinical Pharmacology and Therapeutics (eBook, PDF)31,99 €
- Mark CurrivanThe Drug Recognition Guide (eBook, PDF)25,99 €
- David MachinSample Sizes for Clinical, Laboratory and Epidemiology Studies (eBook, PDF)84,99 €
- David L. SchlossbergAntibiotics Manual (eBook, PDF)76,99 €
- Justina Orleans-LindsayPharmacovigilance Medical Writing (eBook, PDF)44,99 €
-
-
-
This classic, field-defining textbook, now in its sixth edition, provides the most comprehensive guidance available for anyone needing up-to-date information in pharmacoepidemiology. This edition has been fully revised and updated throughout and continues to provide a rounded view on all perspectives from academia, industry and regulatory bodies, addressing data sources, applications and methodologies with great clarity.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in D ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Wiley
- Erscheinungstermin: 18. Oktober 2019
- Englisch
- ISBN-13: 9781119413370
- Artikelnr.: 58045145
- Verlag: Wiley
- Erscheinungstermin: 18. Oktober 2019
- Englisch
- ISBN-13: 9781119413370
- Artikelnr.: 58045145
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
The Editors Brian L. Strom is Chancellor, Rutgers Biomedical and Health Sciences and Executive Vice President for Health Affairs, Rutgers University, Newark, NJ, USA. Stephen E. Kimmel is Professor of Medicine and Director of the Division of Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Sean Hennessy is Professor of Epidemiology and Director of the Center for Pharmacoepidemiology Research and Training, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Contributors x
Preface xix
Acknowledgments xxiii
Part I Introduction 1
1 What is Pharmacoepidemiology? 3
Brian L. Strom
2 Basic Principles of Clinical Pharmacology Relevant to Pharmacoepidemiologic Studies 27
Jeffrey S. Barrett
3 Basic Principles of Clinical Epidemiology Relevant to Pharmacoepidemiologic Studies 44
Brian L. Strom
4 Sample Size Considerations for Pharmacoepidemiologic Studies 60
Brian L. Strom
5 When Should One Perform Pharmacoepidemiologic Studies? 71
Brian L. Strom
Part II The Role of Pharmacoepidemiology in Different Sectors 81
6 The Role of Pharmacoepidemiology in the Healthcare System and Academia 83
Joshua J. Gagne and Jerry Avorn
7 The Role of Pharmacoepidemiology in Industry 98
Nicolle M. Gatto, Rachel E. Sobel, Jamie Geier, Jingping Mo, Andrew Bate, and Robert F. Reynolds
8 The Role of Pharmacoepidemiology in Regulatory Agencies 126
Gerald J. Dal Pan, June Raine, and Shinobu Uzu
9 Pharmacoepidemiology and the Law 140
Aaron S. Kesselheim and Kerstin N. Vokinger
Part III Sources of Data for Pharmacoepidemiology Research 165
Part IIIa Spontaneous Reporting 167
10 Postmarketing Spontaneous Pharmacovigilance Reporting Systems 169
Gerald J. Dal Pan, Marie Lindquist, and Kate Gelperin
Part IIIb Electronic Data Systems 203
11 Overview of Electronic Databases in Pharmacoepidemiology 205
Brian L. Strom
12 Encounter Databases 211
Tobias Gerhard, Yola Moride, Anton Pottegård , and Nicole Pratt
13 Electronic Health Record Databases 241
Daniel B. Horton, Harshvinder Bhullar, Lucy Carty, Francesca Cunningham, Alexis Ogdie, Janet Sultana, and Gianluca Trifiro
14 Inpatient Databases 290
James A. Feinstein, Peter K. Lindenauer, Chris Feudtner, and Brian T. Fisher
Part IIIc Studies Involving Ad Hoc Data Collection 305
15 Event Monitoring in the UK 307
Vicki Osborne and Saad A.W. Shakir
16 Primary Data Collection for Pharmacoepidemiology 342
Nancy A. Dreyer, Ana Filipa Macedo, and Priscilla Velentgas
Part IIId Choosing a Data Source 355
17 Choosing among the Available Data Sources for Pharmacoepidemiology Research 357
Brian L. Strom
Part IV Selected Applications of Pharmacoepidemiology 373
18 Studies of Drug Utilization 375
Björn Wettermark, Vera Vlahovic-Palcevski, David Lee, and Ulf Bergman
19 Evaluating and Improving Physician Prescribing 411
Christine Y. Lu, the late Sumit R. Majumdar, Helene Lipton, and Stephen B. Soumerai
20 Pharmacoepidemiologic Studies of Vaccine Safety 437
Robert T. Chen, Jason M. Glanz, and Tom T. Shimabukuro
21 Epidemiologic Studies of Medical Devices: Methodologic Considerations for Implantable Devices 496
Danica Marinac-Dabic, Sharon-Lise Normand, Art Sedrakyan, and Thomas P. Gross
22 Research on the Effects of Medications in Pregnancy and in Children 524
Daniel B. Horton, Sonia Hernandez-Diaz, Tamar Lasky, and Krista F. Huybrechts
23 Study of Biologics and Biosimilars 561
Jeffrey R. Curtis and James D. Lewis
24 Risk Management 581
Claudia Manzo, Emil Cochino, Lubna Merchant, and Giampiero Mazzaglia
25 Distributed Networks of Databases Analyzed Using Common Protocols and/or Common Data Models 617
Sengwee Toh, Nicole Pratt, Olaf Klungel, Joshua J. Gagne, and Robert W. Platt
26 Comparative Effectiveness Research 639
Soko Setoguchi and Ian Chi Kei Wong
27 Data Mining and Other Informatics Approaches to Pharmacoepidemiology 675
Andrew Bate, Gianluca Trifirò, Paul Avillach, and Stephen J.W. Evans
28 Pharmacoepidemiologic Research on
Preface xix
Acknowledgments xxiii
Part I Introduction 1
1 What is Pharmacoepidemiology? 3
Brian L. Strom
2 Basic Principles of Clinical Pharmacology Relevant to Pharmacoepidemiologic Studies 27
Jeffrey S. Barrett
3 Basic Principles of Clinical Epidemiology Relevant to Pharmacoepidemiologic Studies 44
Brian L. Strom
4 Sample Size Considerations for Pharmacoepidemiologic Studies 60
Brian L. Strom
5 When Should One Perform Pharmacoepidemiologic Studies? 71
Brian L. Strom
Part II The Role of Pharmacoepidemiology in Different Sectors 81
6 The Role of Pharmacoepidemiology in the Healthcare System and Academia 83
Joshua J. Gagne and Jerry Avorn
7 The Role of Pharmacoepidemiology in Industry 98
Nicolle M. Gatto, Rachel E. Sobel, Jamie Geier, Jingping Mo, Andrew Bate, and Robert F. Reynolds
8 The Role of Pharmacoepidemiology in Regulatory Agencies 126
Gerald J. Dal Pan, June Raine, and Shinobu Uzu
9 Pharmacoepidemiology and the Law 140
Aaron S. Kesselheim and Kerstin N. Vokinger
Part III Sources of Data for Pharmacoepidemiology Research 165
Part IIIa Spontaneous Reporting 167
10 Postmarketing Spontaneous Pharmacovigilance Reporting Systems 169
Gerald J. Dal Pan, Marie Lindquist, and Kate Gelperin
Part IIIb Electronic Data Systems 203
11 Overview of Electronic Databases in Pharmacoepidemiology 205
Brian L. Strom
12 Encounter Databases 211
Tobias Gerhard, Yola Moride, Anton Pottegård , and Nicole Pratt
13 Electronic Health Record Databases 241
Daniel B. Horton, Harshvinder Bhullar, Lucy Carty, Francesca Cunningham, Alexis Ogdie, Janet Sultana, and Gianluca Trifiro
14 Inpatient Databases 290
James A. Feinstein, Peter K. Lindenauer, Chris Feudtner, and Brian T. Fisher
Part IIIc Studies Involving Ad Hoc Data Collection 305
15 Event Monitoring in the UK 307
Vicki Osborne and Saad A.W. Shakir
16 Primary Data Collection for Pharmacoepidemiology 342
Nancy A. Dreyer, Ana Filipa Macedo, and Priscilla Velentgas
Part IIId Choosing a Data Source 355
17 Choosing among the Available Data Sources for Pharmacoepidemiology Research 357
Brian L. Strom
Part IV Selected Applications of Pharmacoepidemiology 373
18 Studies of Drug Utilization 375
Björn Wettermark, Vera Vlahovic-Palcevski, David Lee, and Ulf Bergman
19 Evaluating and Improving Physician Prescribing 411
Christine Y. Lu, the late Sumit R. Majumdar, Helene Lipton, and Stephen B. Soumerai
20 Pharmacoepidemiologic Studies of Vaccine Safety 437
Robert T. Chen, Jason M. Glanz, and Tom T. Shimabukuro
21 Epidemiologic Studies of Medical Devices: Methodologic Considerations for Implantable Devices 496
Danica Marinac-Dabic, Sharon-Lise Normand, Art Sedrakyan, and Thomas P. Gross
22 Research on the Effects of Medications in Pregnancy and in Children 524
Daniel B. Horton, Sonia Hernandez-Diaz, Tamar Lasky, and Krista F. Huybrechts
23 Study of Biologics and Biosimilars 561
Jeffrey R. Curtis and James D. Lewis
24 Risk Management 581
Claudia Manzo, Emil Cochino, Lubna Merchant, and Giampiero Mazzaglia
25 Distributed Networks of Databases Analyzed Using Common Protocols and/or Common Data Models 617
Sengwee Toh, Nicole Pratt, Olaf Klungel, Joshua J. Gagne, and Robert W. Platt
26 Comparative Effectiveness Research 639
Soko Setoguchi and Ian Chi Kei Wong
27 Data Mining and Other Informatics Approaches to Pharmacoepidemiology 675
Andrew Bate, Gianluca Trifirò, Paul Avillach, and Stephen J.W. Evans
28 Pharmacoepidemiologic Research on
Contributors x
Preface xix
Acknowledgments xxiii
Part I Introduction 1
1 What is Pharmacoepidemiology? 3
Brian L. Strom
2 Basic Principles of Clinical Pharmacology Relevant to Pharmacoepidemiologic Studies 27
Jeffrey S. Barrett
3 Basic Principles of Clinical Epidemiology Relevant to Pharmacoepidemiologic Studies 44
Brian L. Strom
4 Sample Size Considerations for Pharmacoepidemiologic Studies 60
Brian L. Strom
5 When Should One Perform Pharmacoepidemiologic Studies? 71
Brian L. Strom
Part II The Role of Pharmacoepidemiology in Different Sectors 81
6 The Role of Pharmacoepidemiology in the Healthcare System and Academia 83
Joshua J. Gagne and Jerry Avorn
7 The Role of Pharmacoepidemiology in Industry 98
Nicolle M. Gatto, Rachel E. Sobel, Jamie Geier, Jingping Mo, Andrew Bate, and Robert F. Reynolds
8 The Role of Pharmacoepidemiology in Regulatory Agencies 126
Gerald J. Dal Pan, June Raine, and Shinobu Uzu
9 Pharmacoepidemiology and the Law 140
Aaron S. Kesselheim and Kerstin N. Vokinger
Part III Sources of Data for Pharmacoepidemiology Research 165
Part IIIa Spontaneous Reporting 167
10 Postmarketing Spontaneous Pharmacovigilance Reporting Systems 169
Gerald J. Dal Pan, Marie Lindquist, and Kate Gelperin
Part IIIb Electronic Data Systems 203
11 Overview of Electronic Databases in Pharmacoepidemiology 205
Brian L. Strom
12 Encounter Databases 211
Tobias Gerhard, Yola Moride, Anton Pottegård , and Nicole Pratt
13 Electronic Health Record Databases 241
Daniel B. Horton, Harshvinder Bhullar, Lucy Carty, Francesca Cunningham, Alexis Ogdie, Janet Sultana, and Gianluca Trifiro
14 Inpatient Databases 290
James A. Feinstein, Peter K. Lindenauer, Chris Feudtner, and Brian T. Fisher
Part IIIc Studies Involving Ad Hoc Data Collection 305
15 Event Monitoring in the UK 307
Vicki Osborne and Saad A.W. Shakir
16 Primary Data Collection for Pharmacoepidemiology 342
Nancy A. Dreyer, Ana Filipa Macedo, and Priscilla Velentgas
Part IIId Choosing a Data Source 355
17 Choosing among the Available Data Sources for Pharmacoepidemiology Research 357
Brian L. Strom
Part IV Selected Applications of Pharmacoepidemiology 373
18 Studies of Drug Utilization 375
Björn Wettermark, Vera Vlahovic-Palcevski, David Lee, and Ulf Bergman
19 Evaluating and Improving Physician Prescribing 411
Christine Y. Lu, the late Sumit R. Majumdar, Helene Lipton, and Stephen B. Soumerai
20 Pharmacoepidemiologic Studies of Vaccine Safety 437
Robert T. Chen, Jason M. Glanz, and Tom T. Shimabukuro
21 Epidemiologic Studies of Medical Devices: Methodologic Considerations for Implantable Devices 496
Danica Marinac-Dabic, Sharon-Lise Normand, Art Sedrakyan, and Thomas P. Gross
22 Research on the Effects of Medications in Pregnancy and in Children 524
Daniel B. Horton, Sonia Hernandez-Diaz, Tamar Lasky, and Krista F. Huybrechts
23 Study of Biologics and Biosimilars 561
Jeffrey R. Curtis and James D. Lewis
24 Risk Management 581
Claudia Manzo, Emil Cochino, Lubna Merchant, and Giampiero Mazzaglia
25 Distributed Networks of Databases Analyzed Using Common Protocols and/or Common Data Models 617
Sengwee Toh, Nicole Pratt, Olaf Klungel, Joshua J. Gagne, and Robert W. Platt
26 Comparative Effectiveness Research 639
Soko Setoguchi and Ian Chi Kei Wong
27 Data Mining and Other Informatics Approaches to Pharmacoepidemiology 675
Andrew Bate, Gianluca Trifirò, Paul Avillach, and Stephen J.W. Evans
28 Pharmacoepidemiologic Research on
Preface xix
Acknowledgments xxiii
Part I Introduction 1
1 What is Pharmacoepidemiology? 3
Brian L. Strom
2 Basic Principles of Clinical Pharmacology Relevant to Pharmacoepidemiologic Studies 27
Jeffrey S. Barrett
3 Basic Principles of Clinical Epidemiology Relevant to Pharmacoepidemiologic Studies 44
Brian L. Strom
4 Sample Size Considerations for Pharmacoepidemiologic Studies 60
Brian L. Strom
5 When Should One Perform Pharmacoepidemiologic Studies? 71
Brian L. Strom
Part II The Role of Pharmacoepidemiology in Different Sectors 81
6 The Role of Pharmacoepidemiology in the Healthcare System and Academia 83
Joshua J. Gagne and Jerry Avorn
7 The Role of Pharmacoepidemiology in Industry 98
Nicolle M. Gatto, Rachel E. Sobel, Jamie Geier, Jingping Mo, Andrew Bate, and Robert F. Reynolds
8 The Role of Pharmacoepidemiology in Regulatory Agencies 126
Gerald J. Dal Pan, June Raine, and Shinobu Uzu
9 Pharmacoepidemiology and the Law 140
Aaron S. Kesselheim and Kerstin N. Vokinger
Part III Sources of Data for Pharmacoepidemiology Research 165
Part IIIa Spontaneous Reporting 167
10 Postmarketing Spontaneous Pharmacovigilance Reporting Systems 169
Gerald J. Dal Pan, Marie Lindquist, and Kate Gelperin
Part IIIb Electronic Data Systems 203
11 Overview of Electronic Databases in Pharmacoepidemiology 205
Brian L. Strom
12 Encounter Databases 211
Tobias Gerhard, Yola Moride, Anton Pottegård , and Nicole Pratt
13 Electronic Health Record Databases 241
Daniel B. Horton, Harshvinder Bhullar, Lucy Carty, Francesca Cunningham, Alexis Ogdie, Janet Sultana, and Gianluca Trifiro
14 Inpatient Databases 290
James A. Feinstein, Peter K. Lindenauer, Chris Feudtner, and Brian T. Fisher
Part IIIc Studies Involving Ad Hoc Data Collection 305
15 Event Monitoring in the UK 307
Vicki Osborne and Saad A.W. Shakir
16 Primary Data Collection for Pharmacoepidemiology 342
Nancy A. Dreyer, Ana Filipa Macedo, and Priscilla Velentgas
Part IIId Choosing a Data Source 355
17 Choosing among the Available Data Sources for Pharmacoepidemiology Research 357
Brian L. Strom
Part IV Selected Applications of Pharmacoepidemiology 373
18 Studies of Drug Utilization 375
Björn Wettermark, Vera Vlahovic-Palcevski, David Lee, and Ulf Bergman
19 Evaluating and Improving Physician Prescribing 411
Christine Y. Lu, the late Sumit R. Majumdar, Helene Lipton, and Stephen B. Soumerai
20 Pharmacoepidemiologic Studies of Vaccine Safety 437
Robert T. Chen, Jason M. Glanz, and Tom T. Shimabukuro
21 Epidemiologic Studies of Medical Devices: Methodologic Considerations for Implantable Devices 496
Danica Marinac-Dabic, Sharon-Lise Normand, Art Sedrakyan, and Thomas P. Gross
22 Research on the Effects of Medications in Pregnancy and in Children 524
Daniel B. Horton, Sonia Hernandez-Diaz, Tamar Lasky, and Krista F. Huybrechts
23 Study of Biologics and Biosimilars 561
Jeffrey R. Curtis and James D. Lewis
24 Risk Management 581
Claudia Manzo, Emil Cochino, Lubna Merchant, and Giampiero Mazzaglia
25 Distributed Networks of Databases Analyzed Using Common Protocols and/or Common Data Models 617
Sengwee Toh, Nicole Pratt, Olaf Klungel, Joshua J. Gagne, and Robert W. Platt
26 Comparative Effectiveness Research 639
Soko Setoguchi and Ian Chi Kei Wong
27 Data Mining and Other Informatics Approaches to Pharmacoepidemiology 675
Andrew Bate, Gianluca Trifirò, Paul Avillach, and Stephen J.W. Evans
28 Pharmacoepidemiologic Research on